George Church
Signal active
Co-Founder
Bio
George Church is the Co-Founder of Eugit Therapeutics. He previously worked at Good Start Genetics as an Advisor. George Church attended Harvard University.
Location
Boston, Massachusetts, United States, North America
Social
Primary Organization
Eugit Therapeutics
Founded
2022
Employees
1-10
Industry
Biotechnology
Jobs history
14
Co-Founder and SAB
Invalid date - Current
Dyno Therapeutics
Co-Founder
2018 - Current
Aptah Bio
Scientific Advisory Board Member
2024 - Current
Eugit Therapeutics
Co-Founder
2022 - Current
Flagship Ventures
Advisor
2000 - Current
Arrived Inc.
Co-Founder
2019 - Current
Biophysical Therapeutics
Advisor
Invalid date - Current
Colossal Biosciences Boston, Massachusetts
Co-Founder
2021 - Current
Harton
Strategic Scientific Advisor
2021 - Current
GenEdit
Advisor
2016 - Current
Prime Discoveries
Scientific Advisor
Invalid date - Current
Scientific Strategy Board Member
2016 - Current
EGenesis
Co-Founder
2015 - Current
Nuclera
Scientific Advisor
Invalid date - Current
Board and Advisor Roles
0
N/A
Invest in regions
Profile Resume
George Church is the Co-Founder at Eugit Therapeutics, based in United States, North America. With a background in Biotechnology, George Church has a rich history of leadership and innovation. George Church studied Ph.D Biochemistry & Molecular Biology @ Harvard University. Explore their detailed professional journey, key connections, and contributions to the industry on our platform.
Investment portfolio
George Church has made 2 investments. Their Latest investment was Seed Round - Orchid on Dec 05, 2023
Number of investment
2
Number of exits
0
Personal investment
2
| Annouced Date | Organization Name | Funding Round | Money Raised |
|---|---|---|---|
| Mar 01, 2023 | Thymmune Therapeutics | Seed Round - Thymmune Therapeutics | 7.0M |
| Dec 05, 2023 | Orchid | Seed Round - Orchid | 12.0M |
Partner investment
2
| Annouced Date | Organization Name | Funding Round | Investor Name | Money Raised |
|---|---|---|---|---|
| May 11, 2015 | Joule Unlimited Technologies | Private Equity Round - Joule Unlimited Technologies | Flagship Pioneering | 40.0M |
| Nov 01, 2018 | - | Series E - Axcella | Flagship Pioneering | 59.0M |
Joule Unlimited TechnologiesExits
0
There is no exit available on this Profile
Invest in industries
Recent Activity
There is no recent news or activity for this profile.